Most patients with a new atrial fibrillation diagnosis and an elevated CHA2DS2-VASc score are not prescribed an oral anticoagulant with the first 6 months, contradictory to current guidelines for AF management, researchers reported.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045